Dato-DXd trumps chemo in advanced HR+/HER2– breast cancerOctober 25, 2023Breast CancerMetastatic Breast Cancer
No benefit to adding ICI to chemo in triple-negative breast cancer: studyOctober 22, 2023Breast Cancer
Remote symptom monitoring in advanced cancer improves quality of lifeOctober 22, 2023Breast CancerMetastatic Breast Cancer
Adjuvant abemaciclib-ET combo shows long-term benefit in high-risk early breast cancerOctober 20, 2023Breast Cancer
Similar prognoses for contralateral axillary lymph node metastasis and oligometastatic disease in BCOctober 18, 2023Breast Cancer
Metronomic capecitabine+pyrotinib shows clinical benefits in HER2+ metastatic BC in phase 2October 18, 2023Breast Cancer
First-line palbociclib+AI improves prognosis in elderly patients with metastatic BC in real-world settingsOctober 18, 2023Breast Cancer
Prognostic predictors in breast cancer brain metastases after stereotactic surgeryOctober 18, 2023Breast Cancer
Primary breast tumor surgery does not prolong survival in de novo metastatic BC shows meta-analysisOctober 18, 2023Breast Cancer
Meaningful efficacy and safety with patritumab deruxtecan in heavily pretreated metastatic BC October 18, 2023Breast Cancer
